-
Study aim
-
1- Effect of Ferula assafoetida on:
1-1- Improvement of menstrual status and hirsutism
1-2- Body mass index (BMI) and laboratory tests
1-3- Treatment of ovarian cysts in patients with Polycystic ovarian syndrome
2- It's comparison with Ld tablet.
-
Design
-
Two arm parallel group randomized clinical trial, double-blind, with 30 patients.
-
Settings and conduct
-
The study will be conducted in Mostafa Khomeini hospital in Tehran. Thirty patients with diagnosis of Polycystic ovarian syndrome will be selected and after doing different tests (CBC, LIPID PROFILE, FBS, AST, ALT,ALK.P, TOTAL TESTESTRONE,FREE TESTESTRONE), ovarian ultrasound, hirsutism examination and filling demographic information questionnaires, will enter the study. Patients meeting the inclusion and exclusion criteria randomly will divide into two groups, using a double-blind design. One group will be treated with Ferula Assafoetida capsules (1gram per day) and other group will be treated with OCP (0.03 mg Ethinyl Estradiol and 0.3 mg Norgestrel or 0.15 mg Levonorgestrel). Patients will be asked to use the drugs for three weeks and discontinue the consumption for one week. Thereafter, patients will use the drugs for an extra three weeks. Finally, they will be evaluated after seven to ten days.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 15 to 40 years old women with Polycystic ovarian syndrome.
Exclusion criteria: Pregnancy, diabetes, thyroid diseases, allergy to Ferula Assafoetida, differential Diagnosis cases of PCOS
-
Intervention groups
-
Case group: Intervention with Ferula assafoetida capsule (1 gr per day) for 6 weeks.
Control group: Intervention with ocp (LD tablet: 0.03 mg ethinyl estradiol and 0.3 mg norgestrel or 0.15 mg levonorgestrel) for 6 weeks.
-
Main outcome variables
-
Presence of ovarian cysts, occurrence of menstruation bleeding, hirsutism